Design and Rationale for the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study-Reference-Cited by-同舟云学术

Design and Rationale for the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Published:2023-11 Issue: Volume: Page:
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Dimond Matthew,Looby Mary,Shah Bhruga,Sinha Shashank S.,Isseh Iyad,Rollins Allman T.,Abdul-Aziz Ahmad A.,Kennedy Jamie,Tang Daniel G.,Klein Katherine M.,Casselman Samantha,Vermeulen Christen,Sheaffer Wendy,Snipes Meredith,O'connor Christopher M.,Shah Palak

Funder

National Institutes of Health

Abbott Laboratories

Abbott Laboratories Pleasanton

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure;Rose;N Engl J Med,2001

2. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results;Starling;JACC Heart Fail,2017

3. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure;Uriel;Circulation.,2017

4. Bleeding and thrombosis associated with ventricular assist device therapy;Shah;J Heart Lung Transplant,2017

5. Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week;Grinstein;J Am Coll Cardiol,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices;JACC: Heart Failure;2024-09

2. Clinical outcomes of HeartMate 3 left ventricular assist device support with a Bridge to Transplant vs a Destination Therapy strategy: a single-centre retrospective cohort;Swiss Medical Weekly;2024-07-10